BRIEF published on 04/13/2026 at 07:05, 5 months 29 days ago Innate Pharma: Capital and Voting Rights Update Voting Rights Biotechnology Actions Immunotherapy Innate Pharma
BRIEF published on 04/13/2026 at 07:05, 5 months 29 days ago Innate Pharma Updates Share and Voting Rights as of April 2026 Biotechnology Shares And Voting Rights Innate Pharma April 2026 Euronext Nasdaq
PRESS RELEASE published on 04/13/2026 at 07:00, 5 months 29 days ago Inside Information / Other news releases Innate Pharma to hold its Annual General Meeting of shareholders on May 21, 2026 at 10:30 a.m. CEST in Marseille. Shareholders must register shares by May 14, 2026, 00:00 Paris time, to attend Annual General Meeting Shareholders Registration Innate Pharma Marseille
PRESS RELEASE published on 04/13/2026 at 07:00, 5 months 29 days ago Inside Information / Other news releases Innate Pharma releases total shares and voting rights as of April 9, 2026, in compliance with French regulations. Learn about its innovative immunotherapies for cancer patients Voting Rights Shares French Regulations Innate Pharma Immunothérapies
BRIEF published on 04/03/2026 at 07:05, 6 months 9 days ago Innate Pharma to Join Kempen Life Sciences Conference Biotechnology Investor Meetings Innate Pharma Cancer Immunotherapies Kempen Conference
BRIEF published on 04/03/2026 at 07:05, 6 months 9 days ago Innate Pharma will participate in the Kempen Life Sciences Conference Biotechnology Conference Innate Pharma Immunothérapies Kempen Life Sciences
PRESS RELEASE published on 04/03/2026 at 07:00, 6 months 9 days ago Inside Information / Other news releases Innate Pharma to participate in the Kempen Life Sciences Conference on April 15-16, 2026, in Amsterdam, Netherlands. The company is developing immunotherapies for cancer patients Biotechnology Innate Pharma Immunothérapies Cancer Patients Kempen Life Sciences Conference
BRIEF published on 12/11/2025 at 07:05, 10 months 1 day ago Innate Pharma Announces 2026 Financial Calendar Biotechnology Investor Information Innate Pharma Financial Schedule 2026 Key Dates
BRIEF published on 12/11/2025 at 07:05, 10 months 1 day ago Innate Pharma reveals its 2026 financial calendar Biotechnology Financial Calendar Immunotherapy Innate Pharma 2026 Results
PRESS RELEASE published on 12/11/2025 at 07:00, 10 months 1 day ago Inside Information / Other news releases Innate Pharma releases its 2026 financial calendar, including key dates for financial statements and shareholder meetings. Find details on the company's website Euronext Financial Calendar Nasdaq Innate Pharma 2026
Published on 10/10/2026 at 04:45, 2 days 3 hours ago Immutable Holdings and Jorge Masvidal's Gamebred Fighting Championship (FC) Enter Into Definitive Agreement for Proposed Reverse Takeover Transaction and Listing on the TSXV
Published on 10/10/2026 at 02:03, 2 days 5 hours ago BrandPilot AI Announces Closing of Previously Announced Debt Settlement
Published on 10/10/2026 at 02:00, 2 days 6 hours ago Battery X Metals Reports Estimated Driving Range Increase of Approximately 101 Kilometers Following a Single-Electric-Vehicle Performance Evaluation of Next-Generation Patent-Pending Lithium-Ion Battery Rebalancing Technology
Published on 10/09/2026 at 23:00, 2 days 9 hours ago Trans Canada Gold Closes First Tranche of Non-Brokered Private Placement for Gross Proceeds of CDN $2,144,720
Published on 10/09/2026 at 22:15, 2 days 9 hours ago Loop Industries to Host Second Quarter Fiscal 2027 Earnings Conference Call
Published on 10/12/2026 at 07:00, 1 hour 2 minutes ago EvoNext Holdings SA and Ascend Sport Technology AG sign transaction agreement
Published on 10/12/2026 at 07:00, 1 hour 2 minutes ago Nordex Group order intake rises 29.5% to 2.8 GW in the third quarter of 2026
Published on 10/12/2026 at 06:30, 1 hour 32 minutes ago Centiel obtains UL certification and receives USD 51 million U.S. purchase order; U.S. deliveries expected in 2027 and 2026 guidance revised
Published on 10/12/2026 at 06:05, 1 hour 57 minutes ago SWI Group announces €800 million institutional capital increase at a €6.1 billion final valuation to accelerate the expansion of its transatlantic AI infrastructure and compute platform
Published on 10/12/2026 at 05:00, 3 hours 2 minutes ago ATOMS, Led by Travis Kalanick, Secures $1.7B to Power the Future of Food Delivery with ProKitchens in Europe
Published on 10/09/2026 at 19:27, 2 days 12 hours ago Disclosure of transactions in own shares from October 1 to October 9, 2026
Published on 10/08/2026 at 18:30, 3 days 13 hours ago Cegedim: Release of its 2026 Interim Financial Report
Published on 10/08/2026 at 18:00, 3 days 14 hours ago Launch of LINK, the next generation of THIN: Clinityx’s first European Health Data Warehouse, approved by the French Data Protection Authority for 10 years
Published on 10/08/2026 at 17:45, 3 days 14 hours ago Carrefour announces a real estate sale and leaseback transaction involving 35 stores in France and Spain
